Viewing
|Articles|February 7, 2014

Ranibizumab leading the anti-VEGF evolution

Considerations and new perspectives in anti-VEGF therapy.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe

Latest CME